392 related articles for article (PubMed ID: 17249535)
21. Radical surgery for malignant pleural mesothelioma: results and prognosis.
Okada M; Mimura T; Ohbayashi C; Sakuma T; Soejima T; Tsubota N
Interact Cardiovasc Thorac Surg; 2008 Feb; 7(1):102-6. PubMed ID: 18048410
[TBL] [Abstract][Full Text] [Related]
22. Therapeutic surgery for nonepithelioid malignant pleural mesothelioma: is it really worthwhile?
Balduyck B; Trousse D; Nakas A; Martin-Ucar AE; Edwards J; Waller DA
Ann Thorac Surg; 2010 Mar; 89(3):907-11. PubMed ID: 20172152
[TBL] [Abstract][Full Text] [Related]
23. Prolonged survival after talc poudrage for malignant pleural mesothelioma: case series.
Aelony Y; Yao JF
Respirology; 2005 Nov; 10(5):649-55. PubMed ID: 16268920
[TBL] [Abstract][Full Text] [Related]
24. Treatment results of 17 patients with diffuse pleural mesothelioma.
Liu CC; Hsu WH; Li WY; Huang MH
Ann Thorac Cardiovasc Surg; 1998 Oct; 4(5):233-9. PubMed ID: 9828278
[TBL] [Abstract][Full Text] [Related]
25. Histologic assessment and prognostic factors of malignant pleural mesothelioma treated with extrapleural pneumonectomy.
Arrossi AV; Lin E; Rice D; Moran CA
Am J Clin Pathol; 2008 Nov; 130(5):754-64. PubMed ID: 18854268
[TBL] [Abstract][Full Text] [Related]
26. [Pleural mesothelioma: experience with 62 cases in 9 years].
Villena Garrido V; López Encuentra A; Echave-Sustaeta J; Alvarez Martínez C; Rey Terrón L; Sotelo MT; Ballestín C
Arch Bronconeumol; 2004 May; 40(5):203-8. PubMed ID: 15117619
[TBL] [Abstract][Full Text] [Related]
27. Extrapleural pneumonectomy versus pleurectomy/decortication in the surgical management of malignant pleural mesothelioma: results in 663 patients.
Flores RM; Pass HI; Seshan VE; Dycoco J; Zakowski M; Carbone M; Bains MS; Rusch VW
J Thorac Cardiovasc Surg; 2008 Mar; 135(3):620-6, 626.e1-3. PubMed ID: 18329481
[TBL] [Abstract][Full Text] [Related]
28. Trimodality therapy for malignant pleural mesothelioma.
Buduhan G; Menon S; Aye R; Louie B; Mehta V; Vallières E
Ann Thorac Surg; 2009 Sep; 88(3):870-5; discussion 876. PubMed ID: 19699914
[TBL] [Abstract][Full Text] [Related]
29. Malignant pleural mesothelioma. Multivariate analysis of prognostic factors on 113 patients.
Fusco V; Ardizzoni A; Merlo F; Cinquegrana A; Faravelli B; De Palma M; Chessa L; Nicolò G; Serra M; Capaccio A
Anticancer Res; 1993; 13(3):683-9. PubMed ID: 8317897
[TBL] [Abstract][Full Text] [Related]
30. Phase I to II study of pleurectomy/decortication and intraoperative intracavitary hyperthermic cisplatin lavage for mesothelioma.
Richards WG; Zellos L; Bueno R; Jaklitsch MT; Jänne PA; Chirieac LR; Yeap BY; Dekkers RJ; Hartigan PM; Capalbo L; Sugarbaker DJ
J Clin Oncol; 2006 Apr; 24(10):1561-7. PubMed ID: 16575008
[TBL] [Abstract][Full Text] [Related]
31. [The clinical picture and therapy of malignant pleural mesothelioma].
Schiebe M; Hoffmann W; Kortmann RD; Bamberg M
Strahlenther Onkol; 1994 Nov; 170(11):628-35. PubMed ID: 7526476
[TBL] [Abstract][Full Text] [Related]
32. Pleurectomy/decortication is superior to extrapleural pneumonectomy in the multimodality management of patients with malignant pleural mesothelioma.
Lang-Lazdunski L; Bille A; Lal R; Cane P; McLean E; Landau D; Steele J; Spicer J
J Thorac Oncol; 2012 Apr; 7(4):737-43. PubMed ID: 22425923
[TBL] [Abstract][Full Text] [Related]
33. [Long-term prognostic analysis of patients with malignant pleural mesothelioma].
Cao KJ; Cui NJ
Ai Zheng; 2005 Jan; 24(1):72-5. PubMed ID: 15642204
[TBL] [Abstract][Full Text] [Related]
34. A retrospective analysis of malignant pleural mesothelioma patients treated either with chemotherapy or best supportive care between 1990 and 2005 A single institution experience.
Metintas M; Ak G; Erginel S; Alatas F; Yildirim H; Kurt E; Metintas S
Lung Cancer; 2007 Mar; 55(3):379-87. PubMed ID: 17174436
[TBL] [Abstract][Full Text] [Related]
35. Open lung-sparing surgery for malignant pleural mesothelioma: the benefits of a radical approach within multimodality therapy.
Nakas A; Trousse DS; Martin-Ucar AE; Waller DA
Eur J Cardiothorac Surg; 2008 Oct; 34(4):886-91. PubMed ID: 18656373
[TBL] [Abstract][Full Text] [Related]
36. Trimodality therapy for malignant pleural mesothelioma: results from an EORTC phase II multicentre trial.
Van Schil PE; Baas P; Gaafar R; Maat AP; Van de Pol M; Hasan B; Klomp HM; Abdelrahman AM; Welch J; van Meerbeeck JP;
Eur Respir J; 2010 Dec; 36(6):1362-9. PubMed ID: 20525721
[TBL] [Abstract][Full Text] [Related]
37. A feasibility study of induction pemetrexed plus cisplatin followed by extrapleural pneumonectomy and postoperative hemithoracic radiation for malignant pleural mesothelioma.
Yamanaka T; Tanaka F; Hasegawa S; Okada M; Soejima T; Kamikonya N; Fukuoka K; Nakano T
Jpn J Clin Oncol; 2009 Mar; 39(3):186-8. PubMed ID: 19131427
[TBL] [Abstract][Full Text] [Related]
38. The role of muscle flap in preventing bronchus stump insufficiency after pneumonectomy for malignant pleural mesothelioma in high-risk patients.
Beshay M; Carboni G; Hoksch B; Reymond MA; Schmid RA
Interact Cardiovasc Thorac Surg; 2008 Aug; 7(4):621-4; discussion 624-5. PubMed ID: 18381361
[TBL] [Abstract][Full Text] [Related]
39. Multimodality strategies in malignant pleural mesothelioma.
Weder W; Opitz I; Stahel R
Semin Thorac Cardiovasc Surg; 2009; 21(2):172-6. PubMed ID: 19822290
[TBL] [Abstract][Full Text] [Related]
40. [Malignant mesothelioma of the pleura].
Erika V; Zoltán S; Miklós Z; Judit A; Akos L; Kálmán K
Orv Hetil; 1996 Feb; 137(5):233-8. PubMed ID: 8882441
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
